RFX1 and malaise: Mice injected with EF variants containing a tertiary destabilizing amino acid (EF-(M) N, or EF-C) showed more advanced signs of malaise at later times relative to the mice challenged with EF-A (Figure 4B), and also succumbed with a delay, between 36 and 54 h (Figure 4A).